Tairo Kashihara

Tokyo National Hospital

Papers

1

Total Citations

6

H-Index

1

About

Tairo Kashihara is a leading figure in radiation oncology, with a focused expertise in ultrahypofractionated treatments for prostate cancer. His major contribution lies in the comparative analysis of high-dose-rate brachytherapy (HDR-BT) against robotic and conventional stereotactic body radiotherapy (SBRT), providing critical insights into treatment planning for this increasingly popular approach. His landmark 2023 study, which has already garnered 6 citations, systematically evaluates the dosimetric and clinical trade-offs between these modalities, helping to guide clinical decision-making for optimal patient outcomes. By elucidating the strengths and limitations of each technique, Kashihara’s work directly impacts the precision and efficacy of prostate cancer care. His research is essential reading for clinicians and physicists seeking to refine ultrahypofractionation protocols, and his ongoing contributions continue to shape the landscape of modern radiation therapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Treatment planning comparison of high-dose-rate brachytherapy vs. robotic and conventional stereotactic body radiotherapy for ultrahypofractionated treatment of prostate cancer
6 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Tokyo National Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago